OTCM
ELIXF
, Last price
USD
Name
Elixxer Ltd
Chart & performance
P/E
—
P/B
—
EPS
—
Vol. 1Y
—
Shs. 5Y
14.47%
Rev. 5Y
0.00%
Div Yld LY
—
Div Yld TTM
—
Revenues
0
Net income
-4m
L+111,460.32%
CFO
-705k
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Elixxer Ltd. operates as an investment company specifically focused on the cannabis industry. This firm strategically deploys capital into fully licensed businesses engaged in the cultivation, production, and sale of medicinal and specialized cannabis, as well as cannabis-derived products, predominantly for the pharmaceutical sector. Its investment reach extends across Canada, Australia, Italy, Jamaica, and Switzerland. Founded in 2004, the Montreal, Canada-based company adopted its current name, Elixxer Ltd., in August 2019, having previously been known as LGC Capital Ltd.
Key people
Ferras Zalt
Executive Chairman of the Board · since 2019
John A. D. McMullen
President · since 2019
Chief Executive Officer · since 2019
Remy Di Meglio
Chief Operating Officer · since 2018
Corporate Controller · since 2018
Michael Kozub
Corporate Secretary · since 2018
Mohammed Ghafari
Director · since 2016
Rafi Hazan
Director · since 2018
Co-Chairman of the Board · since 2017
Director · since 2019
Legal address
800 Square-Victoria
Suite 3700
Montreal H4Z 1E9
CA
Suite 3700
Montreal H4Z 1E9
CA
Headquarters
65 Queen Street West
Suite 1125
Toronto, ON M5H 2M5
CA
Suite 1125
Toronto, ON M5H 2M5
CA
Valuation
Title CAD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑09 | 2018‑09 | 2017‑09 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||